Found: 185
Select item for more details and to access through your institution.
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 625, doi. 10.1007/s10637-016-0368-1
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 1, p. 368, doi. 10.1007/s10637-010-9523-2
- By:
- Publication type:
- Article
Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 387, doi. 10.1007/s10637-008-9126-3
- By:
- Publication type:
- Article
Arsenic trioxide represses constitutive activation of NF-?B and COX-2 expression in human acute myeloid leukemia, HL-60.
- Published in:
- Journal of Cellular Biochemistry, 2005, v. 94, n. 4, p. 695, doi. 10.1002/jcb.20337
- By:
- Publication type:
- Article
L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60.
- Published in:
- Journal of Cellular Biochemistry, 2004, v. 93, n. 2, p. 257, doi. 10.1002/jcb.20116
- By:
- Publication type:
- Article
Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Nongastric marginal zone B-cell lymphoma: Analysis of 247 cases.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 6, p. 446, doi. 10.1002/ajh.20874
- By:
- Publication type:
- Article
Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.
- Published in:
- American Journal of Hematology, 2002, v. 71, n. 2, p. 75, doi. 10.1002/ajh.10168
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502
- By:
- Publication type:
- Article
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 83, doi. 10.4143/crt.2021.1571
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 292, doi. 10.4143/crt.2019.186
- By:
- Publication type:
- Article
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 623, doi. 10.4143/crt.2018.151
- By:
- Publication type:
- Article
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117
- By:
- Publication type:
- Article
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 493, doi. 10.4143/crt.2018.125
- By:
- Publication type:
- Article
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 119, doi. 10.4143/crt.2018.019
- By:
- Publication type:
- Article
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-Mutated Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 408, doi. 10.4143/crt.2018.138
- By:
- Publication type:
- Article
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 880, doi. 10.4143/crt.2016.442
- By:
- Publication type:
- Article
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
- By:
- Publication type:
- Article
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 4, p. 906, doi. 10.4143/crt.2016.424
- By:
- Publication type:
- Article
East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1177, doi. 10.4143/crt.2015.401
- By:
- Publication type:
- Article
Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 527, doi. 10.4143/crt.2015.249
- By:
- Publication type:
- Article
Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
- By:
- Publication type:
- Article
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 645, doi. 10.4143/crt.2014.144
- By:
- Publication type:
- Article
Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 871, doi. 10.4143/crt.2014.141
- By:
- Publication type:
- Article
Tumor Lysis Syndrome in a Solid Tumor: A Case Report of a Patient with Invasive Thymoma.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Monensin-mediated growth inhibition in acute myelogenous leukemia cells via cell cycle arrest and apoptosis.
- Published in:
- International Journal of Cancer, 2002, v. 101, n. 3, p. 235, doi. 10.1002/ijc.10592
- By:
- Publication type:
- Article
Low-Density Lipoprotein-Mimicking Nanoparticles for Tumor-Targeted Theranostic Applications.
- Published in:
- Small, 2015, v. 11, n. 2, p. 222, doi. 10.1002/smll.201303277
- By:
- Publication type:
- Article
Imaging: Low-Density Lipoprotein-Mimicking Nanoparticles for Tumor-Targeted Theranostic Applications (Small 2/2015).
- Published in:
- Small, 2015, v. 11, n. 2, p. 146, doi. 10.1002/smll.201570009
- By:
- Publication type:
- Article
Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0194730
- By:
- Publication type:
- Article
Dual-Energy CT in Patients Treated with Anti-Angiogenic Agents for Non-Small Cell Lung Cancer: New Method of Monitoring Tumor Response?
- Published in:
- Korean Journal of Radiology, 2012, v. 13, n. 6, p. 702, doi. 10.3348/kjr.2012.13.6.702
- By:
- Publication type:
- Article
Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
- By:
- Publication type:
- Article
A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.578756
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
- Published in:
- Journal of Korean Neurosurgical Society, 2021, v. 64, n. 2, p. 271, doi. 10.3340/jkns.2020.0135
- By:
- Publication type:
- Article
Focal Thyroid Lesions Incidentally Identified by Integrated <sup>18</sup>F-FDG PET/CT: Clinical Significance and Improved Characterization.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 4, p. 609
- By:
- Publication type:
- Article
Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell Lines.
- Published in:
- Cancer Science, 1999, v. 90, n. 7, p. 733, doi. 10.1111/j.1349-7006.1999.tb00808.x
- By:
- Publication type:
- Article
Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 125, n. 2, p. 331, doi. 10.1007/s11060-015-1915-x
- By:
- Publication type:
- Article
Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 2154, doi. 10.3390/curroncol29030174
- By:
- Publication type:
- Article
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
- Published in:
- European Journal of Endocrinology, 2022, v. 186, n. 6, p. 631, doi. 10.1530/eje-21-1259
- By:
- Publication type:
- Article
Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience.
- Published in:
- European Journal of Endocrinology, 2021, v. 184, n. 6, p. 837, doi. 10.1530/EJE-20-1482
- By:
- Publication type:
- Article
High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer.
- Published in:
- Yonsei Medical Journal, 2012, v. 53, n. 6, p. 1120, doi. 10.3349/ymj.2012.53.6.1120
- By:
- Publication type:
- Article